What is it?

Many people have a medical condition named severe primary axillary hyperhidrosis better known to you as severe underarm sweating. Severe underarm sweating is a medical condition that involves overactive sweat glands. Sweat is your body’s temperature regulator. In severe primary axillary hyperhidrosis, sweating significantly exceeds the body’s normal requirements for cooling.

As you probably know, people with the condition do a lot to cope:

  • Change clothes frequently
  • Put absorbent materials under clothing
  • Avoid certain fabrics and styles of clothes
  • Seek medical attention and treatment

While people with severe underarm sweating may choose many different antiperspirants, in some instances those products do not work well enough for their sweating.

When clinical strength antiperspirants do not work well enough, ask if Neurotoxintreatment could be right for you.

How it works.

Neuromodulators (such as botox, xeomin or disport) are approved by the FDA to treat the symptoms of severe underarm sweating when medicines used on the skin (topical) do not work well enough. Neurotoxin is injected into the affected areas to help control this condition by temporarily blocking the chemical signals from the nerves that stimulate the sweat glands. When the sweat glands don’t receive chemical signals, the severe sweating stops. Neurotoxin injections are expected to temporarily stop the production of excessive sweat in the treated areas only. Sweat continues to be produced elsewhere.

Where does the sweat go?

Your sweat doesn’t go anywhere or get backed up because the sweat simply is not produced in the areas treated with Neurotoxins. Remember, the rest of your body is free to produce moisture normally.

Meeting your needs.

Neurotoxin treatment is proven. In a clinical study involved 322 patients with severe underarm sweating:*

  • Half of the patients had a treatment duration of at least 201 days or 6.7 months.1
  • 57 out of 104 Neurotoxin treated patients (55%) achieved an effective response—compared to only 6 out of 108 treated without Neurotoxin (6%). Patients were defined as “responders” if they showed improvement greater than or equal to 2 grades on the HDSS from the start of the study to 4 weeks after their first 2 treatment sessions, or if they had a sustained response after treatment 1 and did not receive re-treatment during the study.
  • 84 out of 104 Neurotoxintreated patients (81%) achieved a greater than 50% reduction in sweating—compared to only 44 out of 108 treated without Neurotoxin(41%).
Results were based on patients’ responses to a questionnaire (The Hyperhidrosis Disease Severity Scale [HDSS]) that assessed the extent to which underarm sweating affected their daily activities

Neurotoxin treatment is not a cure; your symptoms will return gradually, and you will know when the time is right for another treatment. Your healthcare provider will recommend a treatment strategy to ensure that you receive the best possible results with Neurotoxin treatment.

More information at:     http://sweatless.ca/